Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | HTR2 T cells |
| Synonyms | |
| Therapy Description |
Limited information is currently available on HTR2 T cells, a putative chimeric antigen receptor (CAR) T-cell therapy targeting ERBB2 (HER2) and TRAIL-R2 (Feb 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| HTR2 T cells | HTR2 T-Cells | HER2 (ERBB2) Immune Cell Therapy 9 | Limited information is currently available on HTR2 T cells, a putative chimeric antigen receptor (CAR) T-cell therapy targeting ERBB2 (HER2) and TRAIL-R2 (Feb 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06251544 | Phase I | HTR2 T cells | TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer | Not yet recruiting | USA | 0 |